Science AI Journal

Try Pre-Check Free

Recent papers on benign stress hyperplasia cells reference

Sorted by publication year (newest first) via OpenAlex. List regenerates every 24h.

Systemic Oxidative and Nitrosative Stress in Benign Prostatic Hyperplasia
2026 · Antioxidants · Biesiadecki, Marek, Galiniak, Sabina, Balawender, Krzysztof et al.
2026
Myricetin alleviates testosterone-induced benign prostatic hyperplasia by attenuating inflammation, oxidative stress, apoptosis and androgen signaling
2026 · Scientific Reports · Alomari, Ghada, Al-Trad, Bahaa, Qar, Janti et al.
2026
Oxidative stress reprograms benign prostatic hyperplasia microenvironments: insights from integrative multi-omics and machine learning
2026 · Journal of Translational Medicine · Chen, Jie, Bai, Jingxing, Chen, Bo et al.
2026
Immune–Prostate Axis: The Role of Oxidative Stress and Inflammatory Mediators in the Pathogenesis of Benign Prostate Hyperplasia (BPH)
2026 · IDOSR JOURNAL OF SCIENCE AND TECHNOLOGY · H., Kibibi Wairimu
2026
PARAMETERS OF OXIDATIVE STRESS IN PATIENTS WITH BENIGN PROSTATE HYPERPLASIA, CHRONIC PROSTATITIS, AND PROSTATE CANCER
2025 · AFMN Biomedicine · Veljković, Andrej, Hadži-Đokić, Jovan, Bašić, Dragoslav et al.
2025
Relationship of Growth Differentiation Factor-15, E-Cadherin, Galectin-3, and Psychological Stress with Quality of Life and Prostate Size in Benign Prostatic Hyperplasia
2025 · Urology Research and Practice · Balamurali, PD, Nandeesha, Hanumanthappa, Sreenivasan, Sreerag Kodakkattil
2025
The Intersection of Benign Prostatic Hyperplasia and Reproductive Hormones: Oxidative Stress, Inflammation, and Immunomodulatory Pathway
2025 · NEWPORT INTERNATIONAL JOURNAL OF PUBLIC HEALTH AND PHARMACY · Fortunate, Abaho Areeba
2025
What are the safety considerations when prescribing both prazosin and tamsulosin for patients with benign prostatic hyperplasia (BPH) and post-traumatic stress disorder (PTSD)?
2025 · Zenodo (CERN European Organization for Nuclear Research) · Tripdatabase
2025
The pathogenesis of benign prostatic hyperplasia and the roles of Prdx3, oxidative stress, pyroptosis and autophagy:a review
2025 · Frontiers in Oncology · Xiang, Junjie, Zheng, Yuxuan, Chen, Diang et al.
2025
Stigmasterol as a ptotential phytotherapeutic agent for benign prostatic hyperplasia: modulation of inflammation, oxidative stress, and apoptosis
2025 · Molecular Biology Reports · Alomari, Ghada, Al‐Trad, Bahaa, Al-najjar, Aseel et al.
2025
Urinary Inflammatory and Oxidative Stress Biomarkers as Indicators for the Clinical Management of Benign Prostatic Hyperplasia
2025 · International Journal of Molecular Sciences · Jiang, Yuan‐Hong, Lee, Jimmy, Kuo, Hann‐Chorng et al.
2025
Targeting Oxidative Stress in Urological Complications: Emerging Antioxidant Therapies for Benign Prostatic Hyperplasia and Liver Health Crosstalk
2025 · IAA Journal of Applied Sciences · Thalia, Odile Patrick
2025
Prospective observational study of oxidative stress in the pathology of benign prostatic hyperplasia with bladder diverticulum
2025 · PLoS ONE · Yin, Shuijing, Qiu, Yu
2025
Postoperative stress urinary incontinence in patients after various techniques of laser enucleation for benign prostatic hyperplasia
2025 · Urologiia · Dibiraliev, Dibiraliev C.D., Markosyan, Markosyan G.T., Olefir, Olefir Yu.V. et al.
2025
Ripasudil, a Rho kinase inhibitor, attenuates testosterone-induced benign prostatic hyperplasia in rats: targeting inflammation, oxidative stress, and Rho kinase pathways
2025 · Naunyn-Schmiedeberg s Archives of Pharmacology · Aljorani, Randa Hisham, Al-Zubaidy, Adeeb Ahmed, Abdali, Nibrass Taher
2025
Evaluation of the Effect of Finasteride and Tamsulosin on Glucose, Lipid, and Oxidative Stress Factors of Patients with Benign Prostatic Hyperplasia
2025 · SN Comprehensive Clinical Medicine · Sedaghattalab, Moslem, Akbari, Ghaidafeh, Malekzadeh, Mohammad et al.
2025
IP03-19 BENIGN PROSTATIC HYPERPLASIA SURGERY IMPROVES URGE INCONTINENCE RATES WITHOUT AFFECTING STRESS INCONTINENCE RATES: A PATIENT REPORTED OUTCOMES ASSESSMENT
2025 · The Journal of Urology · Hines, Laena, Ceraolo, Carl, Konar, Soumya et al.
2025
Effect of Cuscuta reflexa Extract in Mitigating Testosterone-Induced Benign Prostatic Hyperplasia in Rats: Targeting Inflammation and Oxidative Stress
2025 · Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) · Aljorani, Randa Hisham, Al-Zubaidy, Adeeb Ahmed, Abdali, Nibrass Taher
2025
Role of Inflammation and Oxidative Stress in Benign Prostatic Hyperplasia Progression
2025 · INOSR EXPERIMENTAL SCIENCES · I., Omeye Francis
2025
Oxidative Stress in Benign Prostatic Hyperplasia: Mechanisms, Clinical Relevance and Therapeutic Perspectives
2025 · Diseases · Kaltsas, Aris, Giannakas, Timoleon, Stavropoulos, Marios et al.
2025
Grip strength, a predictor of stress urinary incontinence after endoscopic enucleation of the prostate for benign prostate hyperplasia
2025 · World Journal of Urology · Song, Hong-Chen, Wu, Menghua, Han, Dong Yup et al.
2025
Thymelaea hirsuta extract attenuates testosterone-induced benign prostatic hyperplasia in rats: Effect on oxidative stress, inflammation and apoptosis
2025 · Journal of Ethnopharmacology · Feki, Inès, Hadrich, Fatma, Mahmoudi, Asma et al.
2025
The profile of oxidative stress markers (arachidonic and linoleic acid derivatives) in patients with benign prostatic hyperplasia in relation to metabolic syndrome
2025 · Aging · Ratajczak, Weronika, Walczakiewicz, Kinga, Laszczyńska, Maria et al.
2025
HSPA1B Overexpression Induces Benign Prostatic Hyperplasia Through Enhancing Endoplasmic Reticulum Stress to Promote NLRP3 Inflammasomes-Mediated Pyroptosis
2025 · The Tohoku Journal of Experimental Medicine · Yu, Xingwei, Tan, Hongao, Gao, Yunqiu et al.
2025
Relationship Between Prostate Cancer and Benign Hyperplasia: Role of Inflammation-Induced Oxidative Stress, Vitamin C, and Epigenetics
2025 · The World Journal of Men s Health · Zarakowska, Ewelina, Guz, Jolanta, Gackowski, Daniel et al.
2025
Transurethral Plasmakinetic Resection of the Prostate on Benign Prostatic Hyperplasia: Observation of Stress Injury and Analysis of Factors Associated with Postoperative Urinary Tract Infection
2025 · Archivos Españoles de Urología · Yang, Kewei, Luo, Tianbo
2025
NOSTRIN is involved in benign prostatic hyperplasia via inhibition of proliferation, oxidative stress, and inflammation in prostate epithelial cells
2024 · Translational Andrology and Urology · Li, Shoubin, Yu, Chunhong, Xiao, Helong et al.
2024
In vitro Validation of the Therapeutic Potential of Diallyl Disulfide on Benign Prostatic Hyperplasia: Effect on Hyperproliferation, Oxidative Stress and Inflammation
2024 · International Journal of Pharmacology · Lou, Zhen-Yuan, Zhang, Weijie, Wang, Jie et al.
2024